Biohaven stock plummeted Thursday after the company paused enrollment in a midstage study of its seizure treatment due to safety concerns. The post Biohaven Plummets, A Boon For Rival Xenon, On A Surprise Seizure Setback appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real